Yasar Ahmed, Dennehy C, Jordan E and Calvert P
Globally, lung cancer is the leading cause of death from cancer among men and women. The overall 5-year survival rate of lung cancer is around 16-19%. The emergence of targeted therapy and immunotherapy have changed the treatment paradigm of advanced NSCLC.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 